Table 3.
Comparisons of HRV measurement in patients stratified by eGFR
| |
Normal eGFR (group 1) |
Mild decreased eGFR (group 2) |
Moderate decreased eGFR (group 3) |
P-values |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Mean |
St. Dev. |
Quartiles |
Mean |
St. Dev. |
Quartiles |
Mean |
St. Dev. |
Quartiles |
|
||||||
| 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | ||||||||
| AVNN |
859.7 |
109.4 |
784.1 |
848.9 |
916.8 |
867.8 |
136.4 |
774.9 |
853.5 |
954.4 |
884.4 |
119.0 |
793.6 |
875.4 |
963.4 |
0.525 |
| SDNN |
125.7 |
30.2 |
101.9 |
119.5 |
146.1 |
119.4 |
38.8 |
92.2 |
111.1 |
140.1 |
116.6 |
36.1 |
94.7 |
113.6 |
141.1 |
0.280 |
| SDANN |
113.4 |
32.5 |
90.1 |
108.6 |
137.0 |
106.6 |
38.7 |
78.0 |
99.4 |
129.1 |
105.2 |
36.1 |
81.2 |
104.0 |
132.4 |
0.308 |
| SDNN IDX |
51.9 |
11.8 |
43.2 |
51.4 |
58.9 |
51.2 |
16.5 |
40.7 |
47.4 |
61.1 |
45.4 |
13.7 |
36.2 |
44.3 |
58.3 |
0.168 |
| RMSSD |
32.6 |
12.5 |
24.4 |
30.1 |
38.1 |
35.7 |
18.9 |
22.6 |
30.7 |
42.3 |
35.6 |
14.3 |
24.4 |
33.5 |
42.1 |
0.602 |
| pNN50 |
8.8 |
6.6 |
3.8 |
7.7 |
11.9 |
11.2 |
10.4 |
2.8 |
7.9 |
17.8 |
11.5 |
11.0 |
4.1 |
9.7 |
12.9 |
0.714 |
| TOTPWR |
18224 |
8902 |
11002 |
16124 |
23743 |
17498 |
12477 |
8919 |
13736 |
21744 |
17099 |
10273 |
9648 |
14338 |
24713 |
0.354 |
| ULF |
14919 |
8093 |
8797 |
12379 |
18709 |
14098 |
10139 |
7083 |
10675 |
18458 |
14311 |
8999 |
7867 |
11539 |
20217 |
0.368 |
| VLF |
1815 |
843 |
1184 |
1592 |
2384 |
1872 |
1417 |
961 |
1471 |
2416 |
1368 |
835 |
780 |
1254 |
1959 |
0.071 |
| LF |
861 |
522 |
481 |
711 |
1108 |
823 |
795 |
368 |
601 |
922 |
660 |
460 |
344 |
543 |
925 |
0.123 |
| HF |
629 |
502 |
293 |
471 |
743 |
705 |
715 |
205 |
496 |
815 |
760 |
602 |
251 |
527 |
1230 |
0.626 |
| LF/HF | 1.74 | 0.92 | 1.17 | 1.44 | 2.11 | 1.48 | 0.90 | 0.91 | 1.25 | 1.75 | 1.00 | 0.47 | 0.71 | 0.85 | 1.25 | <0.001 |
St. Dev. standard deviation.
The p-values refer to Kruskal-Wallis test.